Product Information
ENOXAPARIN 300 MG/3 ML VIAL is a generic product labeled by Sanofi-Aventis U.S. LLC, priced at $10.2663 per ML under NDC 00955101601. Its NADAC has been published 466 times since Dec 18, 2013.
FDA first approved this application on Mar 29, 1993. Its Orange Book therapeutic-equivalence code is AP.
The High Outlier badge above means this manufacturer's average price in the enoxaparin sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/3mL
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00955101601
Classification
Generic
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
ENOXAPARIN SODIUMApproval Type
Authorized Generic (NDA)
FDA Application
NDA020164FDA Approved
3/29/1993
TE Code
AP
On Market Since
10/3/2011
Pharmacological Classes
Price Statistics
The NADAC for ENOXAPARIN 300 MG/3 ML VIAL has been published 466 times since Dec 18, 2013, and over the history we have for it it has declined 79.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.2663 per ML |
|---|---|
| All-time high | $68.5340 (Feb 11, 2015) |
| All-time low | $9.8758 (Jun 17, 2026) |
| 52-week high | $11.6405 |
| 52-week low | $9.8758 |
| Median price | $15.7340 |
| Average price | $24.4026 |
| Largest weekly change | -45.9% (Aug 23, 2017) |
| Weeks tracked | 466 |
| Tracking since | Dec 18, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ENOXAPARIN 300 MG/3 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for ENOXAPARIN 300 MG/3 ML VIAL, manufactured by Sanofi-Aventis U.S. LLC, is $10.2663 per ML (NDC 00955101601), effective Aug 19, 2026.
How has the price of ENOXAPARIN 300 MG/3 ML VIAL changed over time?
Over the history we have for it, the NADAC for ENOXAPARIN 300 MG/3 ML VIAL has declined 79.7%. It has been tracked across 466 weekly CMS publications since Dec 18, 2013.
What are the highest and lowest recorded NADAC prices for ENOXAPARIN 300 MG/3 ML VIAL?
Since Dec 18, 2013, the NADAC for ENOXAPARIN 300 MG/3 ML VIAL has ranged from a low of $9.8758 (Jun 17, 2026) to a high of $68.5340 (Feb 11, 2015), with a median of $15.7340 per ML.
Are there cheaper alternatives to ENOXAPARIN 300 MG/3 ML VIAL?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ENOXAPARIN 300 MG/3 ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures ENOXAPARIN 300 MG/3 ML VIAL?
ENOXAPARIN 300 MG/3 ML VIAL (NDC 00955101601) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a generic product.